Nanobiotix S.A. Finance Income Cost
Nanobiotix S.A. (NBTX) reported Finance Income Cost of -EUR 13.14 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:FinanceIncomeCost · last filed 2026-03-31
| Period end | Finance Income Cost 6 month | Finance Income Cost 12 month |
|---|---|---|
| 2025-12-31 | -13.14M EUR 20-F · filed 2026-03-31 | |
| 2025-06-30 | -6.19M EUR 6-K · filed 2025-09-30 | |
| 2024-12-31 | 361.00K EUR 20-F · filed 2026-03-31 | |
| 2024-06-30 | 1.92M EUR 6-K · filed 2025-09-30 | |
| 2023-12-31 | -12.80M EUR 20-F · filed 2026-03-31 | |
| 2023-06-30 | -2.73M EUR 6-K · filed 2024-09-18 | |
| 2022-12-31 | -10.33M EUR 20-F · filed 2025-04-02 | |
| 2022-06-30 | -474.00K EUR 6-K · filed 2023-09-26 | |
| 2021-12-31 | 5.58M EUR 20-F · filed 2024-04-24 | |
| 2021-06-30 | -640.00K EUR 6-K · filed 2022-09-28 | |
| 2020-12-31 | 2.85M EUR 20-F · filed 2023-04-24 | |
| 2020-06-30 | -2.19M EUR 6-K · filed 2021-09-08 | |
| 2019-12-31 | -4.13M EUR 20-F · filed 2022-04-08 | |
| 2018-12-31 | -277.00K EUR 20-F/A · filed 2021-04-08 |